TrialBMC medicine2025

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy for locally advanced rectal cancer: 3-year survival from a phase 2 study.

Zhenyu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.